12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

AbGenomics, Boehringer Ingelheim deal

In December, AbGenomics said it will regain rights to AbGn-168H from Boehringer Ingelheim, effective Feb. 13. The companies mutually terminated the 2005...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >